Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - April, 2026
85 articles
- Yale Medical School Can't Nix Fraudulent Insemination Suit
- Irish Mallinckrodt Unit Stuck In Drug Price-Fixing Suit
- Abbott Hit With $53M Verdict Over Baby Formula Harms
- Split 4th Circ. Backs West Virginia Schoolchildren Vax Law
- Merck Beats 295 Zostavax Suits Over Missed Deadlines
- McKinsey Settles Liability For $125M In Purdue Ch. 11
- Nonprofit Insurer Wants To Seek AstraZeneca Claims Revival
- Alpine Skiing Makes Me A Better Lawyer
- Philly Injection Site Row Judge Rejects Nonprofit's 'Ploy'
- Abiomed Can't Escape Blood Pump Patent Case
- Ecolab Says Personal Injury Law Firm Holding Back $148K
- Ex-Pharmacy Director Denies Using Trade Secrets At New Job
- US Again Urges High Court To Back Drug Price Program
- Fed. Circ. Questions Specificity Needed In Oxy IP Invalidation
- Biz Judge Keeps Doc Class Action Against Luxottica, For Now
- AbbVie Says 340B Program Defines 'Patient' Too Broadly
- States Seek Time For Talks To Settle Drug Price-Fixing Suit
- 3M Settles Ex-Worker's COVID Vax Firing Suit
- FDA Guidance May Move Goalposts For Form 483 Responses
- AstraZeneca Wants 25 Opt-Ins Axed From Pay Bias Suit
- Abbott Urges Ill. Jury To Reject Claims Formula Led To NEC
- 2 Strands Of Patent Law In High Court's 'Skinny Label' Case
- Biopharma-Focused Jeito Wraps 2nd Fund With $1.2B In Tow
- Faegre Drinker Hires 2 Venable FDA Partners In DC
- Redesigned Supplement Partially Cleared In Patent Row
- Calif. Dialysis Bill Violates 1st Amendment, 9th Circ. Says
- Judge Says CPB Couldn't Void Harvard Researcher Visa
- NY Fertility Clinic Agrees To Settle Suit Over Destroyed Eggs
- HHS Must Face States' Suit Over RFK's 'Dramatic Overhaul'
- Data Breach Counsel Chided For Flouting NC Court Rules
- Biogen, Investors Reach Deal In Alzheimer's Drug Litigation
- Minn. Can't Unfreeze $243M In Medicaid Funds, Judge Says
- ImmunityBio Filmmaker Traded On Insider Tip, SEC Says
- Mich. AG Says PBMs Can't Stall Discovery In Drug-Pricing Suit
- Texas AG Says DOGE Data Led To Fraud Investigations
- Boehringer Wants Generic For Blockbuster Jardiance Blocked
- RFK Jr. Tweaks HHS Vaccine Policy Panel Membership Criteria
- Judge Won't Alter $631K SEC Penalty Against Atty
- Ayahuasca Church Urges Judge To Halt DEA Enforcement
- Biz Groups Urge 4th Circ. To End Allergan Overcharge Suit
- Bausch, MSN Laboratories Settle Patent Battle Over IBS Drug
- Splenda Loses Bid To End Scientist's Libel Counterclaim
- Judge Slashes Damages For Natera In Invitae Patent Case
- Why MDLs Slow Down — And How To Speed Them Up
- A Check-Up On HHS' Push To Implement AI Infrastructure
- What A Court Doc Audit Reveals About Erroneous Filings
- Settlement In Sight For Amway, Supplement Co. In TM Dispute
- Pfizer Failed To Warn Of Depo-Provera Cancer Risk, Suit Says
- WilmerHale Adds Regulatory Atty From Mayer Brown In DC
- Catching Up With Delaware's Chancery Court
- Cooley, Wilson Sonsini Steer Neurocrine's $2.9B Soleno Buy
- Case-By-Case Guide As Justices Eye Landmark Pharma Law
- Barnes & Thornburg Snags PFAS Expert From Venable
- SEC Moves To Set Up $40M Investor Fund In Cassava Case
- Legislative Update: Cannabis And Psychedelics Bill Roundup
- EPA Eyes Microplastics, Drugs For Drinking Water Watch List
- Law360 Announces The Members Of Its 2026 Editorial Boards
- Mich. Banking Brief: All The Notable Legal Updates In Q1
- Aetna Escapes COVID Testing Payment Suit In Calif.
- NYC Fights Sanctions Over Discovery In IVF Sex Bias Dispute
- Caterpillar Worker's Bankruptcy Dooms Genetic Privacy Claim
- The Road Ahead For Drug Development In The US
- Georgia Midwifery Laws Violate State Constitution, Suit Says
- Squires Gives Go-Ahead To 5 Patent Reviews, Denies 8
- Petition To Repeal Legal Pot Mobilizes A Showdown In Mass.
- Ex-Pharma Exec Hit With $5.3M Fee Award In Del.
- Alexion Beats Trade Secret Claims In Amyndas Suit
- FDA's Crackdown On Drug Ads Conflicts With Precedent
- Trump Orders 100% Pharma Tariff, Modifies Metals Duties
- Snell & Wilmer Names Life Sciences Pro As San Diego Leader
- Teva $35M Delayed Generic Inhalers Deal Gets Initial OK
- Ultramarathons Make Me A Better Lawyer
- Vape Sellers, Makers Evade Ga. Woman's RICO Scheme Suit
- Ex-Wilson Sonsini M&A Co-Head Rejoins Goodwin In SF
- 7th Circ. Says Ill. BIPA Amendment Applies Retroactively
- Berkshire Must Defend Trulieve In Worker Death Suit
- 3 Federal Circuit Clashes To Watch In April
- DC Cannabis Co. Sues Firm Over Botched Grow Facility
- Harvard Researcher Can Get Docs On Prosecution Motives
- Astellas Beats $115M Milestone Claim In Del. Chancery Ruling
- Mass. Cannabis Businesses Say Repeal Bid Misleads Voters
- PBM Opioid Crisis Suit Stays In Federal Court, Judge Says
- CFO Scores $867K Win In Health Device Co. Wage Suit
- Determining When Engineered Biologics May Be Patentable
- Informal Announcements Are Reshaping FDA Regulations